Skip to main content
SpringerLink
Log in

Oral vaccination

  • Published:
Antonie van Leeuwenhoek Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bacterial Vaccines: R Germanier (ed.) Academic Press Inc. 1984.

  2. Mestecky, J and McGhee, JR: Immunoglobulin A(IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv.Immunol. 40, 153–244, 1987.

    Google Scholar 

  3. Levine, MM, Kaper, JB, Black, RE and Clements, ML: New knowledge on pathogenesis of bacterial enteric infection as applied to vaccine development. Microbiol.Rev. 47, 510–550, 1983.

    Google Scholar 

  4. Black, RE, Levine, MM, Clements, ML, Young, CR, Svennerholm, A-M and Holmgren, J: Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin. Infect.Immun. 55, 1116–1120, 1987.

    Google Scholar 

  5. Hornick, RB, Greisman, SE, Woodward, TE, DuPont, HL, Dawkins, AT and Snyder, MJ: Typhoid fever: pathogenesis and immunological control. New Eng.J.Med. 283, 739–746, 1970.

    Google Scholar 

  6. DuPont, HL, Hornick, RB, Snyder, MJ, Dawkins, AT, Heiner, GG and Woodward, TE: Studies of immunity in typhoid fever: Protection induced by killed oral antigens or by primary infection. Bull. W.H.O. 44, 667–672,1971.

    Google Scholar 

  7. Chuttani, CS, Prakash, K, Vergese, A, Sharma, U, Singha, P and Ghosh, Ray B: Effectiveness of oral killed typhoid vaccine. Bull, W.H.O. 45, 445–450, 1971.

    Google Scholar 

  8. Chuttani, CS, Prakash, K, Gupta, P, Grover, V and Kumar, A: Controlled field trial of a high-dose oral killed typhoid vaccine in India. Bull. W.H.O. 55, 643–644, 1977.

    Google Scholar 

  9. Holmgren, J and Svenmerholm, A-M: Cholera and the immune response. Progr.Allergy. 33, 106-, 1983.

    Google Scholar 

  10. Collins, FM: Vaccines and cell-mediated immunity. Bacteriol.Rev. 38, 371–402, 1974.

    Google Scholar 

  11. Reitman, M: Infectivity and antigenicity of streptomycin-dependent Salmonella typhosa. J.Infect.Dis. 117, 101–107, 1967.

    Google Scholar 

  12. Germanier, R and Furer, E: Isolation and characterization of galE mutant Ty21a of Salmonella typhi: a candidate strain for a live oral typhoid vaccine. J.Infect.Dis. 131, 553–558, 1975.

    Google Scholar 

  13. Gilman, RH, Hornick, RB, Woodward, WE, DuPont, HL, Snyder, MJ, Levine, MM and Libonati, JP: Evaluation of a UDP galactose-4-epimeraseless mutant of Salmonella typhi as a live oral vaccine. J.Infect.Dis. 136, 717–723, 1977.

    Google Scholar 

  14. Wahdan, MH, Serie, C, Cerisier, Y, Sallam, S and Germanier, R: A controlled field trial of live Salmonella typhi Ty21a oral vaccine against typhoid: three-year results. J.Infect.Dis. 145, 292–295, 1982.

    Google Scholar 

  15. Levine MM, Ferreccio C, Black RE, Germanier R and Chilean Typhoid Committee: Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet (i), 1049–1052, 1987.

  16. Hone, DM, Attridge, SR, Forrest, B, Morona, R, Daniels, D, LaBrooy, JT, Bartholomeusz, RCA, Sheerman, DJC and Hackett, J: A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect.Immun. 56, 1326–1333, 1988.

    Google Scholar 

  17. Bacon, GA, Burrows, TW and Yates, M: The effects of biochemical mutation on the virulence of Bacterium typhosum: the virulence of mutants. Br.J.Exp.Pathol. 31, 714–724, 1950.

    Google Scholar 

  18. Bacon, GA, Burrows, TW and Yates, M: The effects of biochemical mutation on the virulence of Bacterium typhosum: the loss of virulence of certain mutants. Br.J.Exp.Pathol. 32, 85–96, 1951.

    Google Scholar 

  19. Hoiseth, SK and Stocker, BAD: Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291, 238–239, 1981.

    Google Scholar 

  20. Stocker, BAD, Hoiseth, SK and Smith, BP: Aromatic-dependent Salmonella spp. as live vaccines in mice and calves. Dev.Biol.Stand. 53, 47–54, 1983.

    Google Scholar 

  21. Smith, BP, Reina-Guerra, M, Hoiseth, SK, Stocker, BAD, Habasha, F, Johnson, E and Merritt, F: Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves. Am.J.Vet.Res. 45, 59–66, 1984.

    Google Scholar 

  22. Mukkur, TKS, McDowell, GH, Stocker, BAD and Lascelles, AK: Protection against salmonellosis in mice and sheep by immunization with aromatic-dependent Salmonella typhimurium. J.Med.Microbiol. 24, 11–19, 1987.

    Google Scholar 

  23. Dougan, G., Maskell, D., Pickard and Hormaeche, CE: Isolation of stable aroA mutants of Salmonella typhi Ty2: Properties and preliminary characterization in mice. Mol.Gen.Genet. 207, 402–405, 1987.

    Google Scholar 

  24. Stocker, BAD: Auxotrophic Salmonella typhi as live vaccine. Vaccine 6, 141–145, 1988.

    Google Scholar 

  25. Levine, MM, Herrington, D, Murphy, JR, Morris, JG, Losonsky, G, Tall, B, Lindberg, AA, Svenson, S, Baqar, S, Edwards, MF and Stocker, B: Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541 Ty and 543 Ty, as live oral vaccines in humans. J.Clin.Invest. 79, 888–902, 1987.

    Google Scholar 

  26. O'Callaghan, D, Maskell, D, Liew, FY, Easmon, CSF and Dougan, G: Characterization of aromatic-and purine-dependent Salmonella typhimurium: attenuation, persistence and ability to induce protective immunity in BALB/c mice. Infect.Immun. 56, 419–423, 1988.

    Google Scholar 

  27. Dougan G, Chatfield S, Pickard D, O'Callaghan D and Maskell D: Construction and characterization of Salmonella vaccine strains harbouring mutations in two different aro genes. J.Infect.Dis. (in press).

  28. Miller IA, Chatfield S, Dougan G, DeSilva L, Joysey HS and Hormaeche CE: Bacteriophage P22 as a vehicle for transducing cosmid gene banks between smooth strains of Salmonella typhimurium: use in identifying a role for aroD in attenuating virulent Salmonella strains. (Submitted).

  29. Curtiss III, R and Kelly, SM: Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect.Immun. 55, 3035–3043, 1987.

    Google Scholar 

  30. Clements, JD and El-Morshidy, S: Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli related diarrhoea. Infect.Immun. 46, 564–569, 1984.

    Google Scholar 

  31. Formal, SB, Baron, LS, Kopecko, DJ, Washington, O, Powell, C and Life, CA: Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form 1 antigen genes into the galE S.typhi Ty21a typhoid vaccine strain. Infect.Immun. 34, 746–750, 1981.

    Google Scholar 

  32. Baron, LS, Kopecko, DJ, Formal, SB, Seid, R, Guerry, P and Powell, C: Introduction of Shigella flexneri 2a type and group antigen genes into oral typhoid vaccine strain Salmonella typhi Ty21a. Infect.Immun. 55, 2797–2801, 1987.

    Google Scholar 

  33. Black, RE, Levine, MJ, Clements, ML, Losonsky, G, Herrington, D, Berman, S and Formal, SB: Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine. J.Infect.Dis. 155, 1260–1265, 1987.

    Google Scholar 

  34. Maskell, D, Sweeney, KJ, O'Callaghan, D, Hormaeche, CE, Liew, FY and Dougan, G: Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems. Microb.Pathogen. 2, 211–221, 1987.

    Google Scholar 

  35. Clements, JD, Lyon, FL, Lowe, KL, Farrand, AL and El-Morshidy, S: Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat labile enterotoxin of Escherichia coli. Infect.Immun. 53, 685–692, 1986.

    Google Scholar 

  36. Sadoff, JC, Ballou, WR, Baron, LS, Majarian, WR, Brey, RN, Hockmeyer, WT, Young, JF, Cryz, JJ, Ou, J, Lowell, GH and Chulay, JD: Oral Salmonella typhimurium vaccine expresing circumsporozoite protein protects against malaria. Science 240, 236–240, 1988

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wellcome Research Laboratories, Beckenham, Kent, UK

    Gordon Dougan, Duncan Maskell, David O'Callaghan, Steve Chatfield & Ian Charles

  2. University of Cambridge, Cambridge, UK

    Carlos Hormaeche

Authors
  1. Gordon Dougan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Duncan Maskell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David O'Callaghan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Steve Chatfield
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ian Charles
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carlos Hormaeche
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dougan, G., Maskell, D., O'Callaghan, D. et al. Oral vaccination. Antonie van Leeuwenhoek 54, 447–451 (1988). https://doi.org/10.1007/BF00461863

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00461863

Keywords

Search

Navigation